MiR-128-3p Inhibits Vascular Smooth Muscle Cell .

3y ago
20 Views
2 Downloads
3.70 MB
11 Pages
Last View : 2m ago
Last Download : 3m ago
Upload by : Giovanna Wyche
Transcription

(2020) 26:116Qu et al. Mol ular MedicineOpen AccessRESEARCH ARTICLEMiR‑128‑3p inhibits vascular smooth musclecell proliferation and migration by repressingFOXO4/MMP9 signaling pathwayChuan Qu , Xin Liu, Yan Guo, Yuhong Fo, Xiuhuan Chen, Jining Zhou and Bo Yang*AbstractBackground: MicroRNAs (miRNAs) have been identified as important participants in the development of atherosclerosis (AS). The present study explored the role of miR-128-3p in the dysfunction of vascular smooth muscle cells(VSMCs) and the underlying mechanism.Methods: Human VSMCs and ApoE knockout (ApoE / ) C57BL/6J mice were used to establish AS cell and animalmodels, respectively. Expression levels of miR-128-3p, forkhead box O4 (FOXO4) and matrix metallopeptidase 9(MMP9) were detected using qRT-PCR and Western blot, respectively. CCK-8, BrdU, and Transwell assays as well as flowcytometry analysis were performed to detect the proliferation, migration and apoptosis of VSMCs. Levels of inflammatory cytokines and lipids in human VSMCs, mice serum and mice VSMCs were also determined. The binding sitebetween miR-128-3p and 3′UTR of FOXO4 was confirmed using luciferase reporter gene assay.Results: MiR-128-3p was found to be decreased in AS patient serum, ox-LDL-treated VSMCs, AS mice serum andVSMCs of AS mice. Transfection of miR-128-3p mimics suppressed the proliferation and migration of VSMCs, accompanied by the promoted apoptosis and the decreased levels of inflammatory cytokines. Further experiments confirmed the interaction between miR-128-3p and FOXO4. Augmentation of FOXO4 or MMP9 reversed the effects ofmiR-128-3p. Besides, miR-128-3p inhibited triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol(LDL-C) but increased high-density lipoprotein cholesterol (HDL-C) in the serum of AS mice.Conclusion: MiR-128-3p repressed the proliferation and migration of VSMCs through inhibiting the expressions ofFOXO4 and MMP9.Keywords: MiR-128-3p, FOXO4, MMP9, Vascular smooth muscle cell, AtherosclerosisIntroductionAtherosclerosis (AS) is an inflammatory vascular disease, which contributes to the pathogenesis of a varietyof cardiovascular diseases (CVD) (Gholipour et al. 2018).CVD remains the cause of about one third of mortalityin the world (Moss and Ramji 2016). However, presently,the early diagnosis of AS is still difficult (Bejarano et al.2018), and the treatment aims at repressing the levels of*Correspondence: doctorqc@163.comDepartment of Cardiology, Renmin Hospital of Wuhan University, WuhanUniversity, Jiefang Road No.238, Wuhan 430060, Hubei, Chinablood lipids, which has no direct effect on the formation of AS plaques (Orekhov and Ivanova 2016). Thedevelopment of AS is elicited by inflammation and thedysfunction of vascular smooth muscle cells (VSMCs)(Paone et al. 2019). After vascular injury, VSMCsundergo phenotype-switching, followed by the releaseof inflammatory factors and the abnormal proliferation and migration, contributing to the formation of ASplaques; receptors such as LOX-1 on the cell membraneof VSMCs, activated by inflammatory factors such asTNF-α, will further promote the inflammatory responsesthrough signaling pathways such as NF-κB, increase the The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, whichpermits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to theoriginal author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images orother third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit lineto the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutoryregulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of thislicence, visit http://creat iveco mmons .org/licen ses/by/4.0/.

Qu et al. Mol Med(2020) 26:116expressions of cell adhesion factors, and thus furtheraccelerate AS development (Byon et al. 2015; Lim andPark 2014; Jang et al. 2017). Therefore, modulating theinflammatory responses and the phenotypes of VSMCs isa potential strategy to repress the development of AS.MicroRNAs (miRNAs) are non-coding RNAs witha length of 19–25nt. Accumulating researches suggestthat miRNAs may be potential diagnostic and therapeutic targets for AS (Laffont and Rayner 2017). For example, miR-181b is found to be significantly increased inAS plaques, and in AS animal models established usingApoE and LDLR knockout mice, miR-181b enhances thestability of AS plaques by inhibiting target genes such asTIMP-3 and Elastin (Gregoli et al. 2017). MiR-128-3p isa tumor suppressor in a variety of tumors. For instance,in breast cancer, miR-128-3p triggers cell cycle arrest incancer cells by repressing LIMK1 (Zhao et al. 2019a). Inrecent years, miR-128-3p has also been found to exert aprotective role in CVD. It has been found that oxidizedlow density lipoprotein (OX-LDL)-treated RAW264.7cells present remarkable reduction of miR-128-3pexpression in a time and dose-dependent manner; whileafter the transfection of miR-128-3p mimics, it was foundthat both apoptosis and inflammatory responses weresuppressed in RAW264.7 cells (Chen et al. 2018). Thissuggests that miR-128-3p can repress ox-LDL-inducedinflammation and oxidative stress in macrophages, andinhibit the progression of AS.Forkhead box protein O4 (FOXO4) is a member of theforkhead box O protein family. In cancer biology, FOXO4is often considered to exert tumor-suppressive effects(Wang et al. 2016). An increasing number of studies havefound that FOXO4 also has a regulatory role in AS development. For example, adiponectin is reported to exertprotective effects on endothelial cells through inhibitingFOXO4 and inactivating NLRP3 inflammasome (Zhanget al. 2019). In ox-LDL-treated VSMCs, aberrant overexpression of lncRNA LINC00341 indirectly promotesthe expression of FOXO4 by down-regulating miR-214,and thus promote the proliferation and migration ofVSMCs (Liu et al. 2019a). Matrix metalloproteinase 9(MMP9) is one of the downstream proteins regulated byFOXO4 (Li et al. (2007)). Previous studies have shownthat MMP9 expression is significantly increased inhuman AS plaques (Balzan and Lubrano 2018); in ananimal model of AS established using rabbits, irbesartan reduces AS lesion area by inhibiting the activationof NF-κB and repressing the expressions of COX-2 andMMP9 (Li et al. 2018).In the present study, we established AS cell models andanimal models using human VSMCs and ApoE knockoutmice, to explore the roles of miR-128-3p, FOXO4 andMMP9 in the dysfunction of VSMCs and their regulatoryPage 2 of 11relationship. It was demonstrated that miR-128-3p,functioning as a protective factor in AS development,repressed the proliferation and migration of VSMCsthrough inhibiting FOXO4/MMP9 axis.Methods and materialsClinical samplesWe collected serum samples derived from 48 patientswho were diagnosed with carotid atherosclerotic plaquein Renmin Hospital of Wuhan University from February2018 to April 2019; meanwhile serum samples derivedfrom 48 healthy volunteers were collected and set ascontrols. All patients and volunteers signed the written informed consent, and this study protocol had beenapproved by the Ethics Committee of Renmin Hospital ofWuhan University. In AS group, the age was 67.4 13.4.27 of the AS patients were male and 21 of the AS patientswere female. The age of healthy volunteers was 68.0 12.The gender composition of healthy volunteers was assame as AS group.The inclusion and exclusion criteria of AS patients wereas follows: Inclusion criteria: (1) abnormal lipid metabolism; (2) over 40 years old; (3) arteriography revealeda narrowing of the lumen caused by AS; (4) the localintraarterial membrane thickness 1.5 mm. Exclusioncriteria: (1) patients with autoimmune diseases or endocrine and metabolic diseases, including multiple arteritis,rheumatoid arthritis, thyroid dysfunction, adrenocortical dysfunction, diabetes etc.; (2) history of stroke, acutemyocardial infarction, etc.; (3) congenital artery stenosis;(4) severe hepatic and renal insufficiency; (5) patientswith malignant tumor or who was receiving anti-tumortreatment such as radiotherapy and chemotherapy; (6)pregnant or lactating women.The inclusion criteria and exclusion criteria of healthyvolunteers were as follows: Inclusion criteria: Physical examination, including examination of blood lipids,blood pressure, blood glucose, electrocardiogram, andmarkers of myocardial injury, etc., revealed no abnormality. Exclusion criteria: (1) diagnosed with AS; (2) historyof cardiac arrest, myocardial infarction, or PCI; (3) pregnant or lactating women.Cell culture and transfectionHuman VSMCs were purchased from the Chinese Academy of Sciences (Shanghai, China). The cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM)(Thermo Fisher, HyClone, UT, USA) containing 10% fetalbovine serum (FBS) (Thermo Fisher Scientific, MA, USA)in 5% C O2 at 37 . The medium was changed every2 days, and the cells were passaged every 4–5 days. Thecells in logarithmic phase were harvested for subsequentexperiments.

Qu et al. Mol Med(2020) 26:116After being trypsinized and resuspended using DMEM,VSMCs were seeded in 6-well plates at a density of5 106 cells / well, and when the cell confluency reached70%, the cells were transfected with pcDNA3.1-FOXO4,pcDNA3.1-MMP9, miR-128-3p mimics, miR-128-3pinhibitors and their corresponding negative controls,respectively. All the above plasmids, miRNAs wereconstructed or synthesized by GenePharma (Shanghai, China). The transfection was performed with Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA,USA). Subsequently, the cells were cultured at 37 C in5% CO2. After 24 h of the transfection, total RNAs wasextracted from the cells and the transfection efficiencywas detected using quantitative real-time polymerasechain reaction (qRT-PCR).VSMCs were treated with 0, 25, 50, 75, and 100 mg/Lox-LDL for 24 h or 100 mg/L ox-LDL for 0, 6, 12, 18, and24 h to establish cell models of AS.Establishment of mouse model with AS40 male C57BL/6J mice aged 6–8 weeks were purchasedfrom Center for Animal Experiment of Wuhan University, of which 30 were apolipoprotein E knockout mice (ApoE / Mice), and 10 were wild-type (WT) C57BL/6Jmice. Of the WT mice, 5 WT mice were fed with normaldiet (ND) and 5 were fed with high-fat diet (containing20% lard oil and 0.25% cholesterol, purchased from KeaoXieli Feed Co., LTD., Beijing, China) for 8 weeks. Of the ApoE / mice, 5 were fed with ND and 25 were fed withHFD to establish AS models. All the mice had free accessto food and water and were housed with humidity of50%–60% at 18–22 C. Manual-controlled room lightingwas used to maintain a 12 h light/12 h dark cycle. 20 ofthese HFD A poE / mice were divided into four groups,5 mice in each group: mimics NC group, miR-128-3pmimics group, inhibitors NC group, and miR-128-3pinhibitors group. After these four groups of mice wereacclimated to the environment for 1 week, miR-128-3pmimics, inhibitors and their corresponding negativecontrols were dissolved in 0.2 mL of saline at a dose of40 mg/kg/days and injected into the mice of corresponding groups through the caudal vein, respectively, every2 weeks. 8 weeks later, the mice were sacrificed, and thechest was opened along the midline. The carotid arterywas observed under stereomicroscope to confirm theAS. The carotid artery was carefully excised. The vascular outer layer was dissected, and the aorta was verticallycut with an ophthalmic scissors, and the intimal layer wasscraped off with cotton swabs, and the vascular smoothmuscle layer was obtained. The carotid smooth musclecells of the mice were isolated and the serum sampleswere collected. The protocols of the animal experimentsPage 3 of 11had been approved by the Animal Experiment EthicsCommittee of Renmin Hospital of Wuhan University.qRT‑PCRTotal RNAs from human VSMCs, mice carotid arterysmooth muscle cells and serum were extracted usingTRIzol reagent and serum RNA extraction kit (Invitrogen, Carlsbad, CA, USA), For quantifying FOXO4 andMMP9, 1 μg of the extracted total RNA was reverselytranscribed into cDNA with PrimeScript-RT Kit (Takara,Kusatsu, Japan) after the purity was determined. Forquantifying miR-128-3p, cDNA was generated via amiRNA reverse transcription kit (Origene, Rockville,MD, USA) according to the manufacturer’s instruction.With cDNA as the template, PCR amplification was performed with SYBR Green Premix Ex Taq II (TaKaRa,Dalian, China) on the Applied Biosystems 7500 Fast DxReal-Time PCR Instrument (Applied Biosystems, Foster City, CA, USA). The primers used in this study wereshown in Table 1. Relative expression was calculated with 2 ΔΔt method.Western blotCells were washed 3 times using pre-cooled PBS. Following that, RIPA lysis buffer (Beyotime Biotechnology, Shanghai, China) containing protease inhibitor wasadded and mixed thoroughly. The cells were placed on icefor 30 min. After centrifuging at 12,000 g for 10 min at4 C, the supernatant was collected and the protein concentration was determined using BCA protein detectionkit (Beyotime Biotechnology, Shanghai, China). Afterthat, the protein sample was subjected to electrophoresis and electrotransfered to PVDF membrane (Millipore,Bedford, MA, USA). After being blocked with 5% skimmilk for 1 h at room temperature, the primary antibodies (anti-FOXO4 antibody, rabbit anti-human polyclonalantibody, 1:1000, ab63254; or anti-MMP9 antibody,Table 1 Primer sequences used in this PCRNameMiR-128-3pPrimer sequencesForward: 5′-GGT CAG TGA ACC GGTC-3′Reverse: 5′-GTG CAG GGT CCG AGGT-3′FOXO4Forward: 5′-CTT TCT GAA GAC TGG CAG GAA TGT G-3′Reverse: 5′-GAT C TA GGT C TA TGA TCG CGG CAG -3′MMP9Forward: 5′-TTC CAA ACC T TT GAG GGC GA-3′Reverse: 5′-CAA AGG CGT CGT CAA TCA CC-3′U6Forward: 5′-CTC GCT TCG GCA GCACA-3′Reverse: 5′-AAC GCT TCA CGA ATT TGC GT-3′β-ActinForward: 5′-CCT GGC ACC CAG CAC AAT -3′Reverse: 5′-TGC CGT AGG TGT CCC T TT G-3′

Qu et al. Mol Med(2020) 26:116rabbit anti-human polyclonal antibody, 1:1000, ab38898)were used to incubate the membranes overnight in ashaker at 4 , and the membranes were then rinsed 3times using TBST the next day. Next, the secondary antibody (goat anti-rabbit IgG, 1:2000, ab205718) was addedand the membranes were incubated for 1 h at room temperature in a shaker. After the membranes being washed3 times using TBST, the protein bands on the membranewere visualized using hypersensitive ECL (Biossci Biotechnology Co, Ltd., Wuhan, China). All antibodies werepurchased from Abcam (Shanghai, China). The intensityof each band was analyzed by Image J software.CCK‑8 assayVSMCs in logarithmic phase were harvested, trypsinizedand centrifuged. After being resuspended and adjusted toa cell density of 1 105 cells/mL using DMEM, the cellswere seeded into 96-well culture plates (100 μL / well)and then cultured at 37 in 5% CO2. After 0, 24, 48, 72,and 96 h of culture, 10 μL of CCK-8 solution (Beyotime,Shanghai, China) was added into each wells, respectivelyand the incubation was continued for 1 h. The absorbance of each well at 450 nm wavelength was measuredusing a microplate reader (ThermoFisher, Waltham, MA,USA). In this assay, each well had three biological replicates and three technical replicates.BrdU assayVSMCs in logarithmic phase were prepared into singlecell suspensions and seeded into 24-well plates (1 105cells/well). 12 h later, BrdU labeled reagents (Beyotime,Shanghai, China) were added into the wells and thecells were incubated for 12 h. Then the cells were incubated with anti-BrdU antibody and DAPI staining solution (Beyotime, Shanghai, China), respectively. Next,three fields of view under the microscope were randomlyselected for cell counting. Cell proliferation rate BrdUpositive cells / DAPI-positive cells. The average of the cellproliferation rates in three fields was adopted as the finalcell proliferation rate.Flow cytometryAnnexinV-FITC/PI apoptosis detection kit (Yeasen Biotech Co., Ltd., Shanghai, China) was employed to detectthe apoptosis of VSMCs. In brief, 1 106 cells in eachgroup were harvested, and resuspended in 100 μL of1 binding buffer, followed by the addition of 5 μL ofAnnexin V-FITC staining solution and 5 μL of PI stainingsolution to the cells, mixed thoroughly and incubated indark at room temperature for 15 min. The apoptosis ratewas detected by flow cytometry within 1 h.Page 4 of 11Transwell assayThe cells in each group were trypsinized, and the cellswere resuspended using DMEM without serum to adjustthe cell density to 1 105 cells/mL, and 200 μL of cellsuspension was added to the upper compartment of theTranswell chamber (Corning, Beijing, China), meanwhile500 μL of DMEM containing 10% FBS was added to thebottom compartment and the cells were cultured at 37 , 5% CO2 for 48 h. After the chamber was removed, thecells on the bottom of the membrane were fixed with 4%paraformaldehyde for 15 min, stained with 0.1% crystalviolet solution for 15 min, and the remaining crystal violet solution was washed off using PBS, and the cells in theupper chamber were cleaned using a cotton swab. Fivefields of view on the membrane under the microscopewere used to count the number of cells and the average was calculated to indicate the migration ability ofVSMCs.Dual‑luciferase reporter gene assayThe genomic DNA was extracted from human VSMCs.Then the FOXO4 3′UTR sequence containing the putative binding site for miR-128-3p was amplified. GeneArt site-directed Mutagenesis PLUS System (ThermoFisher,Waltham, MA, USA) was used to mutated the abovesequences. After gel electrophoresis of the amplifiedproducts, the target sequences were collected, and theabove fragments were inserted into the pmirGLO dualLuciferase miRNA Target expression vector (Promega,Madison, WI, USA) to construct the reporter vectors:FOXO4 wild type (WT) and FOXO4 mutant (MUT).After the sequence of the reporter vectors were validatedby Sangon Biotech (Shanghai, China) with sequencing, the reporter vectors were transfected into the cells,respectively, together with miR-128 mimic or mimicsNC. The medium was discarded after 48 h. The cells werewashed using PBS and then cell lysis buffer was addedto the wells to lyse the cells. After being centrifuged at3000 g for 5 min, the supernatant was harvested forthe detection of luciferase activity with dual-luciferasereporter assay system (Promega, Madison, WI, USA).Determination of inflammatory factorsThe levels of TNF-α, IL-1β and IL-6 in the cell culturesupernatant or mice serum were detected using enzymelinked immunosorbent assay (ELISA) kits (Multisciences,Hangzhou, China) according to the manufacturer’sinstructions.Determination of lipid levelsThe levels of total cholesterol (TC), triglyceride (TG),low-density lipoprotein cholesterol (LDL-C) and

Qu et al. Mol Med(2020) 26:116Page 5 of 11high-density lipoprotein cholesterol (HDL-C) in miceserum were detected using corresponding detection kits(Jiancheng Bioengineering Institute, Nanjing, China)according to the manufacturer’s instructions. poE / mice fed with HFD (Fig. 2d, e). The above resultsAindicated that miR-128-3p expression was abnormallyreduced in the development of AS.Statistical analysisVSMCs were then treated with different concentrations of ox-LDL for different treatment times in vitro.We observed that, the viability of VSMCs was the highest when treated with 100 mg/L ox-LDL for 24 h (Fig. 3a,b). So this condition was used for the subsequent experiments. To investigate the function of miR-128-3p,we transfected miR-128-3p mimics or inhibitors intoVSMCs to up-regulate or inhibit miR-128-3p, resp

50%–60% at 18–22 C. Manual-controlled room lighting was used to maintain a 12 h light/12 h dark cycle. 20 of these HFD ApoE milk for 1 h at room temperature, the primary antibod / mice were divided into four groups, 5 mice in each group: mimics NC group, miR-128-3p mimics group, inhibitors NC group, and miR-128-3p inhibitors group.

Related Documents:

hsa-miR-92a, P-miR-923, hsa-miR-1979, R-miR-739, hsa-miR-1308, hsa-miR-1826, P-miR-1826, and ssc-miR-184 are downregulated during this process. miR-26b, which is upregulated during follicular atresia, increases DNA breaks and promotes granulosa cell apoptosis by directly targeting AT

ktm 250 sx-f 2006-08 vit013 vet013 128.43 128.43 250 sx-f 2009-12 vit013 vet013 cc032 128.43 128.43 65.74 250 sx-f 2013-15 vit043 vet041 cc033 128.43 128.43 83.52 250 exc-f/ 2007-13 vit013 vet013 cc032 xc-f/xcf-w 128.43 128.43 65.74 250 exc-f 2014-15 vit043 vet041 cc033 128.43 128.43 83.52 350 sx-f 2011-15 vit038 vet038 cc033

C: 8 MHz Vascular Probe Detection of peripheral vessels and calcified arteries D: EZ8 8 MHz Vascular Probe Easy location of vessels and maintain during cuff inflation or deflation E: 10 MHz Vascular Probe Detection of smaller vessels *Beam shape and depth for illustrative purposes only. 8 MHz Vascular Probe *EZ8 8 MHz Vascular Probe All XS High

West Indian Med J DOI: 10.7727/wimj.2016.284 MiR-520c and MiR-519d Function as Oncogenes in Esophageal Cancer NG Dasjerdy 1, MS Javad2, G Masoumeh1, A Shahryar 3, M Samaie Nader1 ABSTRACT Objectives: Esophageal cancer is a poorly characterized deadly cancer with a malignancy ra

5’chol modified miR-433 inhibitor) or the scramble control (Ribobio, Guangzhou, China) for 3 consecutive days and subjected to LAD ligation. AAV represents an efficient and safe vector for in vivo gene transfer and serotype 9 is significantly cardiotropic [23-26]. Thus, besides miR-433 antagomir, the cardiotropic miR-433 sponge AAV9 was used to

D2.3: Report on methods for determining the optimum insulation thickness 3 / 83 CITyFiED GA nº 609129 Versions Version Person Partner Date 1st Draft Aliihsan Koca MIR 9 July 2014 2nd Draft Aliihsan Koca MIR 5 September 2014 3rd Draft Aliihsan Koca MIR 17 October 2014 4th Draft Hatice Sözer ITU 13 November 2014 FINAL VERSION Collaborative work MIR, ITU 23 December 2014

between serum and plasma (Kroh EM et al., 2010; McDonald JS et al., 2011; Wang K et al., 2012). We have found that both serum and plasma samples work well for miRNA and RNA detection but that recovery is slightly higher from plasma samples (Figure 1). hsa-let-7c-5p hsa-miR-16-5p hsa-miR-221-3p hsa-miR-21-5p hsa-miR-26a-5p

Research Paper Effect of Population Size and Mutation Rate . . and